Crinecerfont Promising for Congenital Adrenal Hyperplasia
Oral corticotropin-releasing factor type 1 receptor antagonist enables glucocorticoid dosing at physiologic levels while maintaining androstenedione control.
Medscape Medical News
source https://www.medscape.com/viewarticle/crinecerfont-promising-congenital-adrenal-hyperplasia-2024a1000ab4?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/crinecerfont-promising-congenital-adrenal-hyperplasia-2024a1000ab4?src=rss
Comments
Post a Comment